Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
31.20
-1.27 (-3.91%)
At close: Sep 25, 2026, 4:00 PM EDT
30.73
-0.47 (-1.51%)
After-hours: Sep 25, 2026, 7:51 PM EDT
Parabilis Medicines Employees
Parabilis Medicines had 145 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
145
Change
n/a
Growth
n/a
Revenue / Employee
$1,021
Profits / Employee
-$1,597,703
Market Cap
3.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 145 | 0 | - |
| Dec 31, 2025 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| AbCellera Biologics | 562 |
| Xenon Pharmaceuticals | 370 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| IDEAYA Biosciences | 145 |
PBLS News
- 6 days ago - Parabilis Medicines falls -12.5% - TheFly
- 11 days ago - Parabilis Medicines Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 26 days ago - Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Parabilis Medicines appoints Craig Tendler to board of directors - TheFly
- 4 weeks ago - Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D. - GlobeNewsWire
- 5 weeks ago - Parabilis Medicines reports Q2 EPS ($2.32), consensus (24c) - TheFly
- 6 weeks ago - Parabilis Medicines Slides: Corporate presentation - Filings
- 6 weeks ago - Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire